Rheumatoid arthritis in patient with homozygous haemoglobin C disease

Rheumatol Int. 2011 Jun;31(6):801-3. doi: 10.1007/s00296-009-1230-y. Epub 2009 Oct 25.

Abstract

To date, few cases of hemoglobinopathies in patients with rheumatoid arthritis (RA) have been reported (Marino and Mcdonald in J Rheumatol 17:970-972, 1990; Gladman and Bombardier in Arthritis Rheum 30:1065-1068, 1987; Michel et al. in Semin Arthritis Rheum 38:228-240, 2008). These haemoglobin diseases are associated with characteristics abnormalities of the skeleton. Haemoglobin C disease is a benign hemoglobinopathy rarely associated with skeletal disorders [Piéron et al. in la semaine des hôpitaux 57(1-2):22-25, 1981]. We report a case of RA in a 60-year-old woman with homozygous haemoglobin C disease. This coexistence may be a pure coincidence, although we discuss the difficulties with RA treatment in this case due to the unknown effect of anti-rheumatic drugs on the progression of haemoglobin C disease.

Publication types

  • Case Reports

MeSH terms

  • Antirheumatic Agents / therapeutic use
  • Arthritis, Rheumatoid / complications*
  • Arthritis, Rheumatoid / diagnosis
  • Arthritis, Rheumatoid / drug therapy
  • Drug Therapy, Combination
  • Female
  • Glucocorticoids / therapeutic use
  • Hemoglobin C Disease / complications*
  • Hemoglobin C Disease / diagnosis
  • Hemoglobin C Disease / genetics
  • Homozygote
  • Humans
  • Methotrexate / therapeutic use
  • Middle Aged
  • Osteoporosis / complications
  • Osteoporosis / diagnosis
  • Prednisone / therapeutic use
  • Remission Induction

Substances

  • Antirheumatic Agents
  • Glucocorticoids
  • Prednisone
  • Methotrexate